124 related articles for article (PubMed ID: 8021511)
1. Role and effect of TNF-alpha in experimental visceral leishmaniasis.
Tumang MC; Keogh C; Moldawer LL; Helfgott DC; Teitelbaum R; Hariprashad J; Murray HW
J Immunol; 1994 Jul; 153(2):768-75. PubMed ID: 8021511
[TBL] [Abstract][Full Text] [Related]
2. Role and effect of IL-2 in experimental visceral leishmaniasis.
Murray HW; Miralles GD; Stoeckle MY; McDermott DF
J Immunol; 1993 Jul; 151(2):929-38. PubMed ID: 8335921
[TBL] [Abstract][Full Text] [Related]
3. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353
[TBL] [Abstract][Full Text] [Related]
4. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.
Murray HW; Squires KE; Miralles CD; Stoeckle MY; Granger AM; Granelli-Piperno A; Bogdan C
J Immunol; 1992 Mar; 148(6):1858-63. PubMed ID: 1541824
[TBL] [Abstract][Full Text] [Related]
5. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
[TBL] [Abstract][Full Text] [Related]
6. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
7. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
8. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
10. Involvement of membrane-associated TNF in the killing of Leishmania donovani parasites by macrophages.
Lohmann-Matthes ML; Lüttig B; Hockertz S
Behring Inst Mitt; 1991 Feb; (88):125-32. PubMed ID: 2049029
[TBL] [Abstract][Full Text] [Related]
11. Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.
Murray HW; Cervia JS; Hariprashad J; Taylor AP; Stoeckle MY; Hockman H
J Clin Invest; 1995 Mar; 95(3):1183-92. PubMed ID: 7883967
[TBL] [Abstract][Full Text] [Related]
12. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
13. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
Manna PP; Hira SK; Basu A; Bandyopadhyay S
Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
[TBL] [Abstract][Full Text] [Related]
14. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
Murray HW
Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
[TBL] [Abstract][Full Text] [Related]
16. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
[TBL] [Abstract][Full Text] [Related]
18. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
Moore KJ; Labrecque S; Matlashewski G
J Immunol; 1993 May; 150(10):4457-65. PubMed ID: 8482844
[TBL] [Abstract][Full Text] [Related]
19. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
20. An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection.
Allenbach C; Launois P; Mueller C; Tacchini-Cottier F
Eur J Immunol; 2008 Mar; 38(3):720-31. PubMed ID: 18266271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
